Liver ASK1 protects from non‐alcoholic fatty liver disease and fibrosis

Non‐alcoholic fatty liver disease (NAFLD) is strongly associated with obesity and may progress to non‐alcoholic steatohepatitis (NASH) and liver fibrosis. The deficit of pharmacological therapies for the latter mainly results from an incomplete understanding of involved pathological mechanisms. Here...

Descripción completa

Detalles Bibliográficos
Autores principales: Challa, Tenagne D, Wueest, Stephan, Lucchini, Fabrizio C, Dedual, Mara, Modica, Salvatore, Borsigova, Marcela, Wolfrum, Christian, Blüher, Matthias, Konrad, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783644/
https://www.ncbi.nlm.nih.gov/pubmed/31595673
http://dx.doi.org/10.15252/emmm.201810124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783644/
https://www.ncbi.nlm.nih.gov/pubmed/31595673
http://dx.doi.org/10.15252/emmm.201810124

Ejemplares similares